The New York State Attorney General’s Office is suing the manufacturers of prescription opioids, and one family in particular, for their alleged roles in the nationwide opioid crisis.
Among the defendants is Mallinckrodt, a pharmaceutical maker with a plant in the Delaware County Village of Hobart.
The chief target of the litigation is Purdue Pharma and its owners the Sackler family, developers of the opioid painkiller OxyContin.
New York’s lawsuit alleges that the Sacklers’ and Purdue’s aggressive marketing of OxyContin beginning in the mid-1990s led to massive overprescribing and a scourge of dependency, addiction and death.
Once the pills ran out, the lawsuit alleges, many patients craving the same effects turned to cheaper, more potent alternatives such as heroin and fentanyl.
In 2017, Mallinckrodt paid a $35M settlement to the federal government for failing to notify the DEA of excessive orders for the generic version oxycodone.